Keyphrases
Antipsychotics
100%
Patients with Schizophrenia
100%
Randomized Clinical Trial
100%
Cytochrome P450 2D6 (CYP2D6)
100%
CYP2C19
100%
Drug Persistence
100%
Hazard Ratio
80%
Clinical Monitoring
60%
Adverse Effects
40%
Metabolizer
40%
Denmark
20%
Genetic Polymorphism
20%
Psychiatric Hospital
20%
1-year Follow-up
20%
Intervention Group
20%
Trial Registration
20%
Schizophrenia Spectrum Disorders
20%
CYP2D6 Genotype
20%
Poor Metabolizer
20%
Psychotic Symptoms
20%
CYP2C19 Polymorphism
20%
Treatment Failure
20%
Tenth Revision
20%
Gene Polymorphism
20%
Health Problems
20%
Initial Treatment
20%
Testing Effect
20%
Hallucinations
20%
International Statistical Classification of Diseases
20%
3-group
20%
Clinical Utility
20%
Adverse Reactions
20%
Duration of Illness
20%
Group Randomized
20%
Dose Change
20%
Ultrarapid Metabolizer
20%
Dose number
20%
Number of Drugs
20%
Drug-metabolizing Enzymes
20%
Drug Change
20%
Adverse Factors
20%
Enrichment Design
20%
Psychotic Delusion
20%
Predictive Enrichment
20%
Medicine and Dentistry
Randomized Clinical Trial
100%
Genotype
100%
Typical Antipsychotic
100%
CYP2D6
100%
CYP2C19
100%
Hazard Ratio
80%
Adverse Event
60%
Drug Therapy
40%
Disease
20%
Outpatient
20%
Symptom
20%
International Classification of Diseases
20%
Hallucination
20%
Outcome Assessment
20%
Genetic Polymorphism
20%
Delusion
20%
Psychoactive Drug
20%
Drug Metabolizing Enzyme
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Typical Antipsychotic
100%
Randomized Clinical Trial
100%
CYP2D6
100%
CYP2C19
100%
Adverse Event
60%
Pharmacotherapy
40%
Disease
20%
Symptom
20%
Psychotropic Agent
20%
International Classification of Diseases
20%
Hallucination
20%
Drug Metabolizing Enzyme
20%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
CYP2D6
100%
Randomized Clinical Trial
100%
Typical Antipsychotic
100%
CYP2C19
100%
Enzyme
20%
Genetic Polymorphism
20%
International Classification of Diseases
20%
Neuroscience
Typical Antipsychotic
100%
Dementia Praecox
100%
Cytochrome P450 2D6
100%
Cytochrome P450 2C19
100%
Adverse Effect
40%
Genetic Polymorphism
20%
Psychoactive Drug
20%
Hallucination
20%
Delusion
20%
Drug Metabolizing Enzyme
20%